-->
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LifeVantage Corporation (LFVN—OTCBB) announced that for the three-month period ended March 31, 2009, it recorded net revenues of $0.7 million and a loss of $3.1 million, or 12 cents per share. For the three-month period ended March 31, 2008, the company recorded net revenues of $0.8 million and a loss of $0.6 million, or 3 cents per share.
For the nine-month period ended March 31, 2009, the company recorded net revenues of $2.5 million and a loss of $3.8 million, or 15 cents per share, of which approximately $1.5 million, or 6 cents per share, consisted of noncash expenses. Additionally, approximately $0.5 million, or 2 cents per share, consisted of one-time expenses. This compares to net revenues of $2.4 million and a loss of $1.3 million, or 6 cents per share, for the nine-month period ended March 31, 2008.
“During the third quarter, the company has been preparing for our entry into network marketing,” said David W. Brown, LifeVantage President and CEO. “The third-quarter results reflect the costs of preparing the company for significant anticipated growth, and we believe that the greatly increased interest in our company reflects the fact that there is much excitement about the steps we have taken and the progress we’ve made.”
LifeVantage Corporation is a publicly traded, science-based, natural products company, dedicated to helping people reach their health and wellness goals through science-based solutions to oxidative stress. Founded in 2003 and based in Colorado, LifeVantage develops nutraceutical products, including Protandim®, intended to deliver significant health benefits to consumers.
